相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Factors and Hepatitis C Virus Infection
Alexander J. Thompson
GASTROENTEROLOGY (2012)
Vitamin D Binding Protein Gene Polymorphisms and Baseline Vitamin D Levels as Predictors of Antiviral Response in Chronic Hepatitis C
Edmondo Falleti et al.
HEPATOLOGY (2012)
2.5-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files
Erin D. Michos et al.
NUTRITION (2012)
Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
Shirley Abramovitch et al.
GUT (2011)
Complementary Role of Vitamin D Deficiency and the Interleukin-28B rs12979860 C/T Polymorphism in Predicting Antiviral Response in Chronic Hepatitis C
Davide Bitetto et al.
HEPATOLOGY (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
Christian Markus Lange et al.
JOURNAL OF HEPATOLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry
K. E. Barbour et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey
O. M. Gutierrez et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C
Davide Bitetto et al.
TRANSPLANT INTERNATIONAL (2011)
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients
Saif Abu-Mouch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Prevalence of Vitamin D Deficiency in Chronic Liver Disease
J. Arteh et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander J. Thompson et al.
GASTROENTEROLOGY (2010)
Low Vitamin D Serum Level Is Related to Severe Fibrosis and Low Responsiveness to Interferon-Based Therapy in Genotype 1 Chronic Hepatitis C
Salvatore Petta et al.
HEPATOLOGY (2010)
The 25(OH)D/PTH Threshold in Black Women
John F. Aloia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Vitamin D-Binding Protein Directs Monocyte Responses to 25-Hydroxy- and 1,25-Dihydroxyvitamin D
Rene F. Chun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Vitamin D status and calcium metabolism in adolescent Black and White girls on a range of controlled calcium intakes
Connie M. Weaver et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Vitamin D economy in blacks
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Racial and ethnic differences in bone turnover markers in men
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Race, insulin resistance and hepatic steatosis in chronic hepatitis C
Hari S. Conjeevaram et al.
HEPATOLOGY (2007)
Vitamin D replacement for cirrhosis-related bone disease
Bronwyn A. Crawford et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection
Robert J. Fontana et al.
HEPATOLOGY (2006)
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S. Conjeevaram et al.
GASTROENTEROLOGY (2006)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez et al.
GASTROENTEROLOGY (2005)
Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey
R Scragg et al.
DIABETES CARE (2004)
Peginterferon Alfa-2a (40 kd) and ribavirin for Black American patients with chronic HCV genotype 1
LJ Jeffers et al.
HEPATOLOGY (2004)
Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
AJ Muir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease
BP Sawaya et al.
KIDNEY INTERNATIONAL (2003)
Biochemical responses of bone metabolism to 1,25-dihydroxyvitamin D administration in black and white women
F Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
